Comparison · NCT00822692-bc1470eb
Bactrim DS (800/160) Two Tablets PO BID x 7 Days vs Matched Placebo 2 Pills PO BID x 7 Days: Recurrence Rates of Abscesses
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
2 sourcestrial-comparisons-2026-03-23-0.1.0
Cite this record
ConductScience Library. Bactrim DS (800/160) Two Tablets PO BID x 7 Days vs Matched Placebo 2 Pills PO BID x 7 Days: Recurrence Rates of Abscesses. Trial comparisons, record NCT00822692-bc1470eb. Release trial-comparisons-2026-03-23-0.1.0, 23 Mar 2026. https://conductscience.org/library/comparisons/NCT00822692-bc1470eb
On this page
Measures6
Calculated by ConductScience from the counts the trial posted to ClinicalTrials.gov.
| Measure | Value | 95% interval, lower | 95% interval, upper | Method | Note |
|---|---|---|---|---|---|
| Risk in group 1 | 0.087 | 0.0343 | 0.203 | wilson | |
| Risk in group 2 | 0.275 | 0.171 | 0.409 | wilson | |
| Risk difference, group 1 minus group 2 | -0.188 | -0.332 | -0.032 | newcombe hybrid score | |
| Risk ratio, group 1 over group 2 | 0.317 | 0.112 | 0.894 | log | |
| Odds ratio, group 1 over group 2 | 0.252 | 0.0761 | 0.832 | log | |
| Number needed to treat, for one fewer participant with the outcome on Bactrim DS (800/160) Two Tablets PO BID x 7 Days than on Matched Placebo 2 Pills PO BID x 7 Days | 5.33 | 3.01 | 31.3 | from the risk difference interval |
Source ClinicalTrials.gov
Groups2
Group 2 names the comparator: placebo.
| Group | Title | Description | With the outcome | Analysed | ClinicalTrials.gov code |
|---|---|---|---|---|---|
| Group 1 | Bactrim DS (800/160) Two Tablets PO BID x 7 Days | Active Intervention Arm | 4 | 46 | OG000 |
| Group 2 | Matched Placebo 2 Pills PO BID x 7 Days | Placebo arm | 14 | 51 | OG001 |
Source ClinicalTrials.gov
Outcome
- Type
- PRIMARY
- Title
- Recurrence Rates of Abscesses
- Description
- Number of patient with a new abscess in same or different location as previous lesion
- Time frame
- 30 days after incision and drainage
- Population
Source ClinicalTrials.gov
Trial
- Title
- Trial of Septra for Uncomplicated Skin Abscesses in Patients at Risk for Community Acquired Methicillin-Resistant Staphylococcus Aureus Infection
- NCT number
- NCT00822692
- Phases
- NA
- Conditions
- Abscess, Methicillin-Resistant Staphylococcus Aureus Infection
- Interventions
- Trim/ Sulfa DS, placebo
- Lead sponsor
- 59th Medical Wing
- Results first posted
- 2009-09-03
- Results on ClinicalTrials.gov
- https://clinicaltrials.gov/study/NCT00822692?tab=results
Source ClinicalTrials.gov
Source
- Release
- trial-comparisons-2026-03-23-0.1.0
- Release manifest SHA-256
- f66225897fbf258b57ea10bdacfd0347d3cdfda93f7f5685234b7e06ea36fa57
- AACT copy
- 2026-03-23
- Tables read
- outcome_counts.parquet, outcome_measurements.parquet, outcomes.parquet, reported_event_totals.parquet, reported_events.parquet, result_groups.parquet, studies.parquet, ctgov_trial.parquet
Source ClinicalTrials.gov
Sources 2
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions. The measures are ConductScience's calculation from them.
For software
Read this comparison from software.
The record is JSON. No key.
GET https://conductscience.org/api/comparisons/v1/NCT00822692-bc1470eb